UpToDate
Official reprint from UpToDate®
www.uptodate.com ©2017 UpToDate, Inc. and/or its affiliates. All Rights Reserved.

Medline ® Abstract for Reference 56

of '成人癌症患者静脉血栓栓塞症的风险及预防'

56
TI
The prophylaxis of venous thrombosis in patients with cancer undergoing major abdominal surgery: emerging options.
AU
Agnelli G, Caprini JA
SO
J Surg Oncol. 2007;96(3):265.
 
Cancer is a risk factor for venous thromboembolism (VTE). This risk is amplified by treatment with chemotherapy, radiation, or surgery. Thus, patients with cancer undergoing major surgery should receive appropriate prophylaxis. Available agents include low-dose unfractionated heparin (LDUH), low-molecular-weight heparin (LMWH), and Factor Xa inhibitors. Recent data suggest that Factor Xa inhibitors are safe and effective for VTE prevention in patients with cancer undergoing abdominal surgery. Further study in this patient population is warranted.
AD
Stroke Unit and Cardiovascular Medicine, University of Perugia, Perugia, Italy. agnellig@unipg.it
PMID